Biodesix, Inc. (BDSX) — Financial statements
Income statement, balance sheet, and cash flow for Biodesix, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 88↑24.1% | 71↑45.3% | 49↑28.5% | 38↓29.9% | 55 | |
| Cost of Revenue | 17↑7.4% | 16↑19.7% | 13↓8.1% | 14↓53.6% | 31 | |
| Gross Profit | 72↑28.8% | 56↑54.5% | 36↑50.0% | 24↑0.3% | 24 | |
| Operating Expenses | ||||||
| R&D Expenses | 12↑25.5% | 10↓4.3% | 10↓23.8% | 13↑2.4% | 13 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00↓100.0% | 61↑21.7% | 51 | |
| SG&A Expenses | 88↑8.8% | 80↑19.4% | 67↑9.6% | 61↑21.7% | 51 | |
| Other Expenses | 0.00↓100.0% | 0.24↑440.9% | 0.04↓45.7% | 0.08↓95.0% | 2 | |
| Operating Expenses | 100↑10.3% | 90↑16.6% | 77↑3.7% | 75↑15.0% | 65 | |
| Total Costs & Expenses | 116↑9.9% | 106↑17.0% | 90↑1.8% | 89↓7.0% | 95 | |
| Operating Results | ||||||
| Operating Income | -28↑19.5% | -34↑16.6% | -41↑18.3% | -51↓23.6% | -41 | |
| Depreciation & Amortization | 6↑2.7% | 5↓0.9% | 6↓5.8% | 6↑83.9% | 3 | |
| EBITDA | -22↑24.9% | -29↑21.3% | -37↑28.0% | -52↓45.3% | -35 | |
| EBIT | -28↑20.5% | -35↑18.6% | -43↑25.7% | -57↓48.4% | -39 | |
| Interest & Other Income | ||||||
| Net Interest Income | -8↑6.6% | -8↑13.4% | -10↓18.1% | -8↓79.1% | -5 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 8↓6.6% | 8↓13.4% | 10↑18.1% | 8↑79.1% | 5 | |
| Non-Operating Income | -0.22↓224.0% | 0.18↓86.2% | 1↓81.3% | 7↑396.5% | -2 | |
| Other Income / Expenses | -7↑11.1% | -8↑21.9% | -11↑27.3% | -15↓569.7% | -2 | |
| Income Before Tax | -35↑17.9% | -43↑17.7% | -52↑20.3% | -65↓51.6% | -43 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -35↑17.9% | -43↑17.7% | -52↑20.3% | -65↓51.6% | -43 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -35↑17.9% | -43↑17.7% | -52↑20.3% | -65↓51.6% | -43 | |
| Bottom-Line Net Income | -35↑17.9% | -43↑17.7% | -52↑20.3% | -65↓51.6% | -43 | |
| EPS (Basic) | -4.67↑29.2% | -6.60↑48.4% | -12.80↑58.7% | -31.00↑1.9% | -31.60 | |
| EPS (Diluted) | -4.67↑29.2% | -6.60↑48.4% | -12.80↑58.7% | -31.00↑1.9% | -31.60 | |
| Weighted Average Shares | 8↑16.5% | 6↑57.9% | 4↑95.0% | 2↑53.9% | 1 | |
| Weighted Average Diluted Shares | 8↑16.5% | 6↑57.9% | 4↑95.0% | 2↑53.9% | 1 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.